NCT02940587View on ClinicalTrials.gov

Effectiveness of Aurix Therapy in Venous Leg Ulcers

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2015

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Venous Leg Ulcers
Interventions
DEVICE

Aurix

Aurix is a platelet-rich plasma gel used in the treatment of non-healing wounds. It will be administered twice weekly for 2 weeks then weekly.

Trial Locations (1)

83702

St. Luke's Intermountain Research, Boise

Sponsors

Lead Sponsor

Cytomedix
All Listed Sponsors
lead

Cytomedix

INDUSTRY

NCT02940587 - Effectiveness of Aurix Therapy in Venous Leg Ulcers | Biotech Hunter | Biotech Hunter